OR WAIT 15 SECS
EMD Millipore, the life science division of Merck KGaA of Germany, has opened a biopharmaceutical technical and training centre in Shanghai, China.
EMD Millipore, the life science division of Merck KGaA of Germany, has opened a biopharmaceutical technical and training centre in Shanghai, China. The facility will provide support, training and validation services to the company’s biopharmaceutical customers with operations in China.
“We are responding to China’s commitment to strengthen regulatory requirements designed to ensure drug safety,” said Jean-Paul Mangeolle, head of process solutions. “Our new biopharmaceutical technical centre is unique in that we can support and even train our pharmaceutical customers to meet the new Chinese and global regulations. Today we have taken a significant step not only expanding our 30 years of local offerings in China, but also to support the effort to produce safe, quality drugs in this important and fast growing region.”
The centre is located in Zhangjiang Hi-Tech Park and will support biopharmaceutical manufacturers, allowing local and regional customers to investigate, explore and optimize their upstream and downstream processes as well as environmental monitoring processes with the support of the company’s local, regional and international experts. Similar facilities are run by the company in Singapore, Japan, India, France, North America and Brazil.
For more information visit www.millipore.com